Patient Care
The Byers Eye Institute at Stanford University is dedicated to combating blindness and preserving sight. We deliver effective, integrated vision care across all specialties at our state-of-the-art facilities as well as via phone or video.
Make an appointment today by
calling 650-723-6995.
Research
Our premier group of visionary scientists is leading innovations in diagnostics and the next generation of vision restorative therapeutics. Stanford's vision research faculty bring the latest in basic and translational research as well as clinical trials.
Education
Residency training and clinical and research fellowships at Stanford in every specialty as well as fellowships in international health and ophthalmic innovation, offer exciting opportunities to advance the field and develop careers.
Welcome
Jeffrey L. Goldberg, MD, PhD
Professor and Chair
Department of Ophthalmology
Welcome to the Byers Eye Institute in the Department of Ophthalmology at Stanford University School of Medicine, a top-tier, internationally recognized, multidisciplinary center combining world-class resources with a commitment to providing the highest level of diagnostic and therapeutic care to our patients.
Through an integrated, personalized approach to healthcare delivery, our dedicated team provides the latest therapies in treating eye disorders. Associated with Stanford Health Care, and the Lucille-Packard Children's Hospital, our faculty and staff provide excellence in ocular and vision healthcare to patients across Northern California and from around the world, while our cutting-edge team of researchers carries out some of the most innovative laboratory research and clinical trials anywhere.
Whether you are a patient, a resident, or a leader in academic or clinical ophthalmology, I invite you to explore our programs, visit our clinics and operating rooms, and receive your eye care from our premier faculty.
I am very proud of our exceptional faculty and staff and their accomplishments in our mission areas of patient care, research, education and community outreach.
We are here for you.
Read the Vision Matters Annual Report
Where Technology Meets the Eye
Ophthalmology has long been at the forefront of medical innovation, but the pace of those advances has only accelerated in recent years. Throughout this report, you'll see how our faculty are leading that momentum.
The theme of our 2025 Vision Matters annual report, Where Technology Meets the Eye, highlights some of the most exciting advances currently available in our clinics as well as the advances being made in our laboratories and via artificial intelligence that hold great promise to help us reach our goal of eradicating blindness and preserving sight.
Recent News
-
For decades, neuroscientists have understood the visual cortex to function much like a sketch artist, breaking down the world into simple, well-defined edges—such as the borders where light meets shadow—before higher-level brain regions integrate these into complex representations.
-
A New Path for Regenerating and Protecting the Optic Nerve
New research from the Byers Eye Institute at Stanford is uncovering novel insights into how the tiny energy factories known as mitochondria move within the optic nerve as well as a promising new approach to help protect the nerve when that process fails, causing neurodegenerative diseases, like glaucoma.
-
Silicon Chips on the Brain
Fabricated as a single chip, the new implant is orders of magnitude faster and smaller than today’s state-of-the-art brain-computer interfaces, offering an opportunity for more efficacious treatment of a number of neurological conditions…
-
Eye prosthesis is the first to restore sight lost to macular degeneration
In a Stanford Medicine-led clinical trial of a wireless retinal prosthesis, people with advanced macular degeneration regained enough vision to read books and subway signs.
-
 copy.jpg)
First FDA-approved MacTel treatment available at the Byers Eye Institute
The Byers Eye Institute is proud to offer the only FDA-approved treatment for patients diagnosed with macular telangiectasia type 2, known as MacTel. Make an appointment at: 650.723.6995. No center has implanted more of these devices in patients.
From the Annual Report
-
Demystifying ODD
Optic disc drusen (ODD) is one of the oldest known causes of visual impairment, yet one of the least studied. Joyce Liao, MD, PhD, Stanford professor of ophthalmology and professor of neurology and neurological sciences, set out to change that in 2019 when she launched the Stanford Center for Optic Disc Drusen at the Byers Eye Institute.
-
Driven by Hope
The morning of September 27, 2024, started as an ordinary day for Chris Workman, as the entrepreneur, husband, and father of four set out on his usual Saturday morning walk. When he stepped into the Louisiana sun, however, he noticed what could best be described as a “smudge” in the lower half of his vision in his left eye.
-
Tracking glaucoma from home
Robert Chang, MD, associate professor of ophthalmology, and Ann Shue, MD, clinical assistant professor of ophthalmology, are on a mission to allow patients with suspected or diagnosed glaucoma to track the disease’s progression without even leaving their homes.
-
The first FDA-approved MacTel treatments
Retinal degeneration is one of the leading causes of vision loss. For the past 15 years, Diana Do, MD, professor of ophthalmology and vice chair of clinical affairs, has worked with patients diagnosed with one such disease, macular telangiectasia type 2, known as MacTel. Until recently, much of her work with those patients focused on helping them manage the central vision loss that accompanies the disease.
Follow us on Social Media
Upcoming Events
-
June 29, 2026 Bay Area Ophthalmology Course
-
July 28, 2026 Ophthalmic Innovation Symposium
-
September 18, 2026 PILLAR: Program in Lasting Leadership and Academic Representation
